MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'ehrlich'. Sat, 03 Sep 2011 02:49:27 +0100 http://www.medworm.com/index.php?rid=3754078&cid=t_119107_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FngseFNCG0Aw%2F That’s what two professors have concluded after a preliminary study of web sites for the 100 best-selling prescription meds in 2009. Their preliminary analysis, which was presented at a recent conference in Boston, finds the sites are a “bewildering and patchy mess of information” that often make safety data hard to find and makes it hard to distinguish between promotion and education. “Our analysis suggests there is a blurring of the lines which is not in anyone’s interest,” Lewis Glinert, a Dartmouth University linguistics professor and one of the co-authors, tells us. ““There should be a lot more regulation of these websites. The FDA should be more hands-on.” For instance, they found that about three-quarters of the sites provide as much as... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3754078 Wed, 14 Jul 2010 14:55:35 +0100 3754078 http://www.medworm.com/index.php?rid=3499053&cid=t_119107_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FzBeVgiacEu8%2F By Indur GoklanyThis Earth Day we heard various commentators bemoan the growth in population, consumption, and carbon emissions driven by fossil fueled technologies. Once again we are told that this is unsustainable, that we are running out of resources, prices are inevitably headed up, and, worse, such consumption reduces  both environmetal and human well-being. In this worldview, industrialization and economic development were fashioned in the Devil’s crucible, and that de-industrialization and de-development will be our saviour. I have started a series of posts at Master Resources that compares the above Neo-Malthusian view of industrialization, economic growth, and technological change against empirical data on human well-being from the age of industrialization.  The first post rev... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=3499053 Fri, 23 Apr 2010 12:15:35 +0100 3499053 http://www.medworm.com/index.php?rid=3404139&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F03%2Fare-pharma-marketers-drug-pushers.html "Critics may not like branded drugs pushed [my emphasis] directly to consumers but it is clear that it brings people in the doctor's door," wrote Bob Ehrlich, Chairman of DTC Perspectives (see "DTC Supported By Ad Critic"). Note to Bob: Please attach your name to your blog posts. I know this was written by you, but new visitors might not realize that these are your opinions. Also, since I am a bit dyslexic, it will help me remember how to spell your last name!I never expected to see "branded drugs" and "pushed" used in the same sentence by a non-critic like Ehrlich. I suggest that he edit that sentence -- at least put "pushed" in quotes. It elicits an image in the minds of readers that I don't think Ehrlich would approve of.Ehrlich was speaking about direct-to-consumer (DTC) advertising cr... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=3404139 Thu, 25 Mar 2010 12:59:00 +0100 3404139 http://www.medworm.com/index.php?rid=3178983&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F01%2Fif-you-cant-beat-regulators-sig-em-on.html In his latest post to DTC Perspectives Blog, Chairman Bob Ehrlich suggests that the Congress should regulate all health advertising and not just single out Direct-to-Consumer (DTC) advertising by drug companies (see "The Inequality of DTC Regulation")."Congress, as part of a final health reform bill should give FDA or another part of the federal government jurisdiction over health claim advertising," says Ehrlich. "Americans are wasting precious health care dollars on products that do not work as advertised and potentially dangerous."I agree. Ads that promote products that "don't work as advertised" and that are "potentially dangerous" SHOULD be regulated. But isn't that what the Federal Trade Commission (FTC) is for?It's strange for someone who has argued against stricter regulation of th... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=3178983 Fri, 15 Jan 2010 16:42:00 +0100 3178983 http://www.medworm.com/index.php?rid=3176115&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F01%2Fif-you-cant-beat-regulators-sig-em-on.html In his latest post to DTC Perspectives Blog, Chairman Bob Ehrlich suggests that the Congress should regulate all health advertising and not just single out Direct-to-Consumer (DTC) advertising by drug companies (see "The Inequality of DTC Regulation")."Congress, as part of a final health reform bill should give FDA or another part of the federal government jurisdiction over health claim advertising," says Ehrlich. "Americans are wasting precious health care dollars on products that do not work as advertised and potentially dangerous."I agree. Ads that promote products that "don't work as advertised" and that are "potentially dangerous" SHOULD be regulated. But isn't that what the Federal Trade Commission (FTC) is for?It's strange for someone who has argued against stricter regulation of th... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=3176115 Fri, 15 Jan 2010 16:42:00 +0100 3176115 http://www.medworm.com/index.php?rid=2260908&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2009%2F03%2Fwho-are-anti-dtc-bloggers-this-blogger.html (Source: Pharma Marketing Blog) Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=2260908 Fri, 13 Mar 2009 11:39:00 +0100 2260908 http://www.medworm.com/index.php?rid=2240976&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2009%2F03%2Fget-dtc-check-up.html (Source: Pharma Marketing Blog) Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=2240976 Fri, 06 Mar 2009 13:47:00 +0100 2240976 http://www.medworm.com/index.php?rid=2222573&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2009%2F02%2Fdrug-fact-box-it-all-depends-on-what.html (Source: Pharma Marketing Blog) Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=2222573 Fri, 27 Feb 2009 11:22:00 +0100 2222573 http://www.medworm.com/index.php?rid=2182582&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2009%2F02%2Fare-fda-penalties-no-longer-slap-on.html (Source: Pharma Marketing Blog) Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=2182582 Fri, 13 Feb 2009 13:01:00 +0100 2182582 http://www.medworm.com/index.php?rid=2147571&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2009%2F01%2Fwhich-way-will-dtc-wind-blow.html (Source: Pharma Marketing Blog) Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=2147571 Fri, 30 Jan 2009 12:06:00 +0100 2147571 http://www.medworm.com/index.php?rid=2128928&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2009%2F01%2Flets-focus-on-effectiveness-not-dollars.html (Source: Pharma Marketing Blog) Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=2128928 Fri, 23 Jan 2009 12:01:00 +0100 2128928 http://www.medworm.com/index.php?rid=1980669&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F11%2Fscare-balance-or-scare-tactics-weak.html Based on some minimalist data reported in the Wall Street Journal, Bob Ehrlich of DTC Perspectives Blog concludes that "we need to be judicious how we approach patients with side effect information" in direct-to-consumer (DTC) advertising of Rx drugs (see "Fair Balance or Scare Balance"). The WSJ article cited some not-very-scientific research, which "shows" that "expecting to feel ill can bring illness on in some instances" (see "Power of Suggestion: When Drug Labels Make You Sick").Clearly this WSJ article is another example of Ehrlich's expressed perception that the media "[hypes] negative outcomes with their 'death in your medicine cabinet' type stories." NOT!In this case, the media is a great source of questionable research that Ehrlich can use to make a case against current FDA think... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=1980669 Fri, 21 Nov 2008 12:53:00 +0100 1980669 http://www.medworm.com/index.php?rid=1551895&cid=t_119107_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F321395798%2F The latest Harris Interactive poll that examines American attitudes toward corporate America offers a sobering view of and for the pharmaceutical industry. Only 26 percent of Americans view the industry favorably which, of course, means that 74 percent have a negative or neutral impression. And 52 percent are firmly negative, which places pharma slightly below big oil, and above tobacco. Bob Ehrlich of DTC Perspectives notes the warning signs: “The drug industry must decide what improving their reputation is worth. They could accept the second lowest ranking or decide how to make it better. Clearly their current approach has fallen short and anyone charged with making it better has largely failed, unless the goal was a controlled decline. I know all the good things the drug companies... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1551895 Fri, 27 Jun 2008 15:24:08 +0100 1551895 http://www.medworm.com/index.php?rid=1261810&cid=t_119107_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F242276871%2F Over the past month, direct-to-consumer ads have been yanked by different drugmakers. The Vytorin ads were pulled by Schering-Plough and Merck after a firestorm erupted over their handling of a Vytorin clinical trial. And Pfizer earlier this week ended its Lipitor ads featuring artificial heart inventor Bob Jarvik over allegations that the campaign contained misinformation. The backdrop to this activity, of course, comes amid ongoing scrutiny of DTC ads. Congress, for instance, is investigating celebrity ads, prompted in part by the Jarvik ads. And there is growing speculation that a Democrat in the White House will work with Congress to change the rules that have allowed DTC advertising to flourish since 1997. So we spoke with Bob Ehrlich, a former Warner-Lambert marketing exec who heads ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1261810 Wed, 27 Feb 2008 19:21:17 +0100 1261810 http://www.medworm.com/index.php?rid=1250424&cid=t_119107_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F239558763%2F That’s the question Bob Ehrlich, a former Warner-Lambert exec who now runs a consulting firm, mulls over in his weekly blog. In his view, the odds are against a big change in the use of mass media. For the moment, he ballparks the odds on a momentous shift at only 30 percent. But he doesn’t take much comfort in the age-old defense that the First Amendment will preserve DTC. And lobbyists won’t save the day, either. Here’s why… “What if a ‘change’ election occurs, as seems entirely likely? With a likely expansion in Americans covered by health insurance and the resulting costs to do so, what changes might occur to limit cost increases? Hmm, let me think! Drug costs will be a key component. Drug marketing affects cost by emphasizing newer and m... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1250424 Fri, 22 Feb 2008 18:53:52 +0100 1250424 http://www.medworm.com/index.php?rid=1072491&cid=t_119107_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F195629667%2F After a long run of quarterly spending growth, the reported spending for DTC advertising fell 7.1 percent in the third quarter to $1.13 billion, according to DTC Insights, which cites data released this week by Nielsen Monitor-Plus. The decline represented “reported” dollars of $86 million. (For the first nine months of 2007, the reported spending data shows an increase of 2.6 percent to $3.85 billion.) The shift in the third-quarter DTC spending hit network television hard, DTC Insights writes. According to Nielsen data, network TV saw its DTC ad dollars fall 10.1 percent in the quarter to $314.5 million (a drop of more than $35 million). As a result, the firm notes that cable TV surpassed network as the market-share media leader for DTC in the period (28.9 percent market share for c... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1072491 Wed, 05 Dec 2007 17:53:02 +0100 1072491 http://www.medworm.com/index.php?rid=858303&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F09%2Fdo-pharma-marketers-need-thick-skin-or.html Every Friday, I look forward to receiving "DTC In Perspective," Bob Ehrlich's weekly opinion piece. You can access a recent iteration of Bob's OpEd online here.Last Friday, Bob gave his "guidelines" for reviewing DTC (direct-to-consumer) marketing tactics and ads in an article called "DTC Critics." He suggested that because there will be many critics out there, including some who call for the firing of specific marketers, that "It takes a thicker skin to be a good marketer."Of course, this drew my attention for two reasons: (1) I was one of those (unnamed by Bob) critics that suggested somebody be fired, and (2) the "thick-skin" quote suggested the subject of a post that I could write in response to Bob's piece.Unfortunately, Bob's piece is not online yet, so I will quote it in its entiret... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=858303 Mon, 10 Sep 2007 14:22:00 +0100 858303 http://www.medworm.com/index.php?rid=733654&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F07%2Fim-non-objective-and-proud-of-it.html Looking for an objective POV of pharma marketing practices? Forgettaboutit! as they say in my native hometown of Brooklyn, NY. You won't find that here!Bob Ehrlich, in his weekly DTC in Perspective "e-Column" entitled "Beware of Objectivity," covered the topic of objectivity in pharmaceutical-land in his uniquely non-objective fashion. Of course, he admits he himself is non-objective. BTW, you may be able to find his remarks here, although it may take awhile for Bob's Web folks to update this page.Bob talks about the non-objectivity of pharma industry folks, the press, physicians, and himself; but he devotes the most space to bloggers. Here's what Bob says about bloggers:"Bloggers always have some strong point of view, frequently angry and antagonistic. They usually do not like the drug in... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=733654 Fri, 13 Jul 2007 11:53:00 +0100 733654 http://www.medworm.com/index.php?rid=650973&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F06%2Fwhat-is-marketers-goal-legacy-or-sales.html I wasn't going to write about IT, but I just can't help myself!IT happened last week on an episode of the Sopranos.I'm not talking about Tony maneuvering Robert "Bobby Bacala" Baccalieri, Jr. to "pop his cherry" and kill someone as part of a deal to import counterfeit drugs from Canada into the US. That subplot -- no doubt in my mind -- was paid for by PhRMA, the drug industry's trade association and long-time terrorist scare-monger (see "PhRMA's Terrorist Plot").So WHAT am I talking about?Let me try and do this without mentioning any product name (search engine spiders be damned!).I am talking about a DTC ad appearing within the Sopranos -- an ad for a sleep aid medication that features a historical figure in a stove-pipe hat and a creepy woodlands creature that talks.According to DTC exp... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=650973 Fri, 01 Jun 2007 11:27:00 +0100 650973 http://www.medworm.com/index.php?rid=638034&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F05%2Fpodcast-today-mack-vs-ehrlichblogs-vs.html Listen to a FREE! live podcast today at 1 PM Eastern Time!Blogs vs. DTC: What's Best for Consumers?Exploring Blogs as a Counter to Other Sources of Drug and Medical InformationGuest: Bob Ehrlich, Chairman, DTC Perspectives, Inc.Live Podcast Date: Thursday, May 24, 2007, 1 PM Eastern US timeDuration: Approx. 35 minutesGo to the Pharma Marketing Talk Channel Page to listen live or to access the archived audio after the show. Background While blogs are now aimed primarily at industry insiders, one has to wonder when it will be a dominant consumer tool aimed at reviewing drug performance, side effects and risks. Blogs on drug selection may soon be a key tool in spreading word of mouth on new drugs. Consumers will learn to accept blogs as a counter to other sources of medical information, DT... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=638034 Thu, 24 May 2007 16:28:00 +0100 638034 http://www.medworm.com/index.php?rid=623516&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F05%2Fmyth-1-high-us-drug-prices-guarantee-us.html The drug industry often defends higher drug prices in the U.S. by claiming that it guarantees Americans "first shot" at new drugs.Bob Ehrlich at DTC Perspectives stated as much in his e-mail commentary today:"As far as high pricing goes, here is where it can get quite complex. Drug companies need someone to pay high retail prices, because so many countries have price controls. There is not really a palatable explanation to the American public on why drug prices are higher in the U.S. market. The truth is that someone needs to make drug sales profitable and unfortunately it is the American public that is hit with the tab. The benefit is more drug research and a market inspired guarantee that Americans will get first shot at newer drugs. We certainly will appreciate that when a pandemic hits... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=623516 Fri, 18 May 2007 11:16:00 +0100 623516 http://www.medworm.com/index.php?rid=612113&cid=t_119107_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F05%2Fblogs-vs-dtc-whats-best-for-consumers.html The recent DTC moratorium scare from Congress -- which has since dissipated (see "DTC Moratorium Yanked From PDUFA") -- had Direct-to-Consumer (DTC) marketers scrambling to think of a replacement consumer marketing strategy. In that scramble, blogs leaped to mind.One such mind was that of Bob Ehrlich, Chairman at DTC Perspectives, Inc., who writes a weekly e-mail commentary on trends in DTC. His May 4, 2007 piece entitled "Blogs and DTC" posed an interesting question:"While [blogging is] now aimed primarily at industry insiders, one has to wonder when it will be a dominant consumer tool aimed at reviewing drug performance, side effects and risks. Blogs on drug selection may soon be a key tool in spreading word of mouth on new drugs."Ehrlich was thinking about how pharmaceutical marketers c... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=612113 Mon, 14 May 2007 10:52:00 +0100 612113